2016
DOI: 10.1016/j.ijbiomac.2016.06.083
|View full text |Cite
|
Sign up to set email alerts
|

The anti-diabetic activity of oat β-d-glucan in streptozotocin–nicotinamide induced diabetic mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
21
0
9

Year Published

2017
2017
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 49 publications
(32 citation statements)
references
References 33 publications
2
21
0
9
Order By: Relevance
“…In a study with diabetic mice, treatment with β-glucans of different molecular weights showed a hypoglycemic effect, improving insulin secretion and decreasing insulin resistance when compared to untreated animals [ 53 ]. The evaluation of these parameters, as well as the evaluation of the pancreatic β-cell function, can be very useful in studies with diabetic animals.…”
Section: Discussionmentioning
confidence: 99%
“…In a study with diabetic mice, treatment with β-glucans of different molecular weights showed a hypoglycemic effect, improving insulin secretion and decreasing insulin resistance when compared to untreated animals [ 53 ]. The evaluation of these parameters, as well as the evaluation of the pancreatic β-cell function, can be very useful in studies with diabetic animals.…”
Section: Discussionmentioning
confidence: 99%
“…The remodeling of the gut microbiota composition and an increase in SCFA production from substrate fermentation partly explained the beneficial action of oat β ‐glucan . However, an increasing number of studies have suggested that the molecular weight ( M w ) of oat β ‐glucan was strictly related to its bioactivities, including in vitro bile acid binding and fermentation, energy expenditure, gastric emptying and glycemic control, cholesterol‐lowering, and antioxidant and inflammation‐resolving effects . Nevertheless, these findings of recent research on the effects of oat β ‐glucan fractions on its physiological functions were inconsistent, especially the prebiotic response of oat β ‐glucan with differing M w .…”
Section: Introductionmentioning
confidence: 99%
“…So wurde in vitro eine hemmende Wirkung von Hafer-β-Glucan auf die Expression des SGLT-1-Rezeptors (sodiumglucose-linked transport protein-1) sowie des Glukose-tranporteproteins-2 (GLUT-2) in den Darmzellen gezeigt [29]. Darüber hinaus hemmt Hafer-β-Glucan die Alpha-Glucosidase [30]. Das führt mutmaßlich dazu, dass weniger Glukose aus dem Darmlumen aufgenommen wird.…”
Section: Verminderte Glukoseaufnahmeunclassified
“…Sehr interessant ist in diesem Zusammenhang auch, dass in einem Mausmodell für Typ 1 Diabetes, bei dem die Betazellen der Bauchspeicheldrüse durch Streptozotocin-Nicotinamid geschädigt sind, beobachtet wurde, dass Hafer-β-Glucan die Betazellen "repariert" und ihre Integrität verbessert [30]. In der Leber wiederum wurde auf die Gluconeogenese eine hemmende und auf die Glykolyse eine aktivierende Wirkung durch Hafer-ß-Glucan gesehen, die der Wirkung des Diabetes-Medikaments Metformin ähnelt [30].…”
Section: Verminderte Glukoseaufnahmeunclassified